Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study.

Ohrr H, Tandan JB, Sohn YM, Shin SH, Pradhan DP, Halstead SB.

Lancet. 2005 Oct 15-21;366(9494):1375-8.

PMID:
16226615
2.
3.

Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study.

Bista MB, Banerjee MK, Shin SH, Tandan JB, Kim MH, Sohn YM, Ohrr HC, Tang JL, Halstead SB.

Lancet. 2001 Sep 8;358(9284):791-5.

PMID:
11564484
4.

Epidemiological situation of Japanese encephalitis in Nepal.

Bista MB, Shrestha JM.

JNMA J Nepal Med Assoc. 2005 Apr-Jun;44(158):51-6.

PMID:
16554872
5.

Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.

Kumar R, Tripathi P, Rizvi A.

N Engl J Med. 2009 Apr 2;360(14):1465-6. doi: 10.1056/NEJMc0808664. No abstract available.

6.

Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.

Upreti SR, Janusz KB, Schluter WW, Bichha RP, Shakya G, Biggerstaff BJ, Shrestha MM, Sedai TR, Fischer M, Gibbons RV, Shrestha SK, Hills SL.

Am J Trop Med Hyg. 2013 Mar;88(3):464-8. doi: 10.4269/ajtmh.12-0196. Epub 2013 Jan 28.

7.

Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.

Chotpitayasunondh T, Sohn YM, Yoksan S, Min J, Ohrr H.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S195-203.

PMID:
22043776
8.

An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait.

Hanna JN, Smith GA, McCulloch BG, Taylor CT, Pyke AT, Brookes DL.

Aust N Z J Public Health. 2005 Feb;29(1):44-7.

PMID:
15782871
9.

Vaccination Policy for Japanese Encephalitis in India: Tread with Caution!

Vashishtha VM, Ramachandran VG.

Indian Pediatr. 2015 Oct;52(10):837-9.

10.

Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study.

Hennessy S, Liu Z, Tsai TF, Strom BL, Wan CM, Liu HL, Wu TX, Yu HJ, Liu QM, Karabatsos N, Bilker WB, Halstead SB.

Lancet. 1996 Jun 8;347(9015):1583-6.

PMID:
8667866
11.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.

J Infect Dis. 2003 Oct 15;188(8):1213-30. Epub 2003 Oct 3.

PMID:
14551893
12.

Japanese encephalitis: the need for a more effective vaccine.

Marfin AA, Gubler DJ.

Lancet. 2005 Oct 15-21;366(9494):1335-7. No abstract available.

PMID:
16226596
13.

Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?

Choi UY, Lee SY, Kim KH, Kim DS, Choi KM, Cha SH, Kang JH.

J Trop Pediatr. 2013 Oct;59(5):423-5. doi: 10.1093/tropej/fmt043. Epub 2013 Jun 13.

PMID:
23764540
14.

Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.

Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, Sabchareon A, Pancharoen C, Bouckenooghe A, Gailhardou S, Boaz M, Feroldi E.

Pediatr Infect Dis J. 2010 Dec;29(12):1111-7. doi: 10.1097/INF.0b013e3181f68e9c.

PMID:
20856164
15.

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children.

Kwon HJ, Lee SY, Kim KH, Kim DS, Cha SH, Jo DS, Kang JH.

J Korean Med Sci. 2015 May;30(5):612-6. doi: 10.3346/jkms.2015.30.5.612. Epub 2015 Apr 15.

16.

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.

Sohn YM, Tandan JB, Yoksan S, Ji M, Ohrr H.

Vaccine. 2008 Mar 20;26(13):1638-43. doi: 10.1016/j.vaccine.2008.01.021. Epub 2008 Feb 4.

PMID:
18294743
17.

Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.

Sricharoenchai S, Lapphra K, Chuenkitmongkol S, Phongsamart W, Bouckenooghe A, Wittawatmongkol O, Rungmaitree S, Chokephaibulkit K.

Pediatr Infect Dis J. 2017 Feb;36(2):e45-e47. doi: 10.1097/INF.0000000000001395.

PMID:
27846060
18.
19.

Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEVĀ®) in children.

Chokephaibulkit K, Houillon G, Feroldi E, Bouckenooghe A.

Expert Rev Vaccines. 2016;15(2):153-66. doi: 10.1586/14760584.2016.1123097. Epub 2015 Dec 9. Review.

PMID:
26588242
20.

Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy.

Wierzba TF, Ghimire P, Malla S, Banerjee MK, Shrestha S, Khanal B, Sedai TR, Gibbons RV.

Am J Trop Med Hyg. 2008 Jun;78(6):1002-6.

PMID:
18541784

Supplemental Content

Support Center